Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
MorphoSys
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
anetumab ravtansine
(BAY 94-9343) / Bayer
tesidolumab
(LFG316) / Novartis
xentuzumab
(BI-836845) / Boehringer Ingelheim
ecleralimab
(CSJ117) / Novartis
elgemtumab
(LJM-716) / Novartis
carlumab
(CNTO 888) / J&J, Novartis
LKA651
/ Novartis
MOR106
/ Galapagos, Novartis
NOV-8
/ Novartis
befovacimab
(BAY 1093884) / Bayer
BHQ880
/ Novartis
CNTO6785
/ J&J, Fontacea
lirametostat
(CPI-1205) / Novartis
tarextumab
(OMP-59R5) / Mereo Biopharma, Novartis
tulmimetostat
(CPI-0209) / Novartis
CLG561
/ Novartis
